|
|
|
|
||
Re: Global Blood Therapeutics Announces Pivotal Study For GBT440 In Sickle Cell Disease With Primary Hemoglobin Endpointfrom Oct 2016 ? |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
352 | Re: Global Blood Therapeutics Announces Pivotal Study For GBT440 In Sickle Cell Disease With Primary Hemoglobin Endpoint | Asymmetric | 1 | 11/5/2018 6:24:36 PM |